Episode 131

Ep 131: Ozempic/Edward O'Malley designer of the Velo Vetta bike shoe

In this episode:

Ozempic and Wegovy, both trade names of the drug semaglutide have led a kind of weight loss revolution because of the success patients who use them have had in dropping and keeping off weight. The mechanism by which this drug works does have some consequences for any multisport athletes who use or are considering using it and so on the medical mailbag we look at this drug and what multisport athletes should know. Edward O'Malley is an engineer and age group triathlete who saw a need for a better bike shoe so he designed one himself and the result is the VeloVetta. With its unique closure lever and aerodynamic features the shoe has some real promise for making your transitions and bike splits faster. Meet the man behind the shoe and hear why he did what he did.


[03:53]- Medical Mailbag:

[32:52]- Interview: Edward O'Malley


Edward's Facebook page

@velovetta on Instagram

Edward's Website

Edward on YouTube

About the Podcast

Show artwork for The TriDoc Podcast, triathlon and health in one place
The TriDoc Podcast, triathlon and health in one place
A fresh take on all things triathlon with a special focus on health and wellness topics. Train hard, train healthy.

About your host

Profile picture for Jeffrey Sankoff

Jeffrey Sankoff

Jeff Sankoff is an emergency physician, multiple Ironman finisher and the TriDoc. Jeff owns TriDoc Coaching and is a coach with LifeSport Coaching. Living in Denver with his wife and three children, Jeff continues to race triathlons while producing the TriDoc podcast.